医学临床研究
   May. 9, 2025    Home  |  About Journal  |  Editorial Board  |  Instruction  |  Subscribe  |  Advertisement  |  Messages Board  |  Contact Us  |  中文
JOURNAL OF CLINICAL RESEARCH  2022, Vol. 39 Issue (4): 524-527    DOI: 10.3969/j.issn.1671-7171.2022.04.013
Original Articles Current Issue | Archive | Adv Search |
Clinical Efficacy and Safety of Caffeine Citrate Combined with Noninvasive Respiratory Support in the Treatment of Neonatal Severe Aspiration Pneumonia
ZHANG Fen-xia, FENG Cheng-hu, WU Xiao-yu, et al
Yan'an People's Hospital,Yan'an Shaanxi 716000
Download: PDF (1184 KB)   HTML (1 KB) 
Export: BibTeX | EndNote (RIS)      
Abstract  【Objective】 To investigate the clinical efficacy and safety of caffeine citrate combined with noninvasive respiratory support in the treatment of neonatal severe aspiration pneumonia. 【Methods】 A total of 70 newborns with severe aspiration pneumonia treated in our hospital from June 2018 to April 2020 were prospectively selected and randomly divided into observation group (caffeine citrate combined with nasal continuous positive airway pressure ventilation,n= 34) and control group (caffeine citrate combined with nasal synchronous intermittent positive pressure ventilation,n= 36). The indexes of pulmonary function, respiratory mechanics and serum insulin-like growth factor binding protein-3 (IGFBP-3) and β- Endorphins(β- EP) were compared between the two groups,and the incidence of complications were also compared. 【Results】 After treatment, tidal volume (TV), peak time ratio (TPTEF/TE), peak volume ratio (VPEF/VE) and peak expiratory flow rate (PEF) in the two groups were higher than those before treatment (P<0.05), respiratory rate (RR), functional residual capacity (FRC) and effective airway resistance were lower than those before treatment (P<0.05), and there were significant differences between the observation group and the control group (P<0.05); The oxygenation index and lung compliance of the two groups were higher than those before treatment (P<0.05), and the inspiratory resistance was lower than that before treatment (P<0.05). There was significant difference between the observation group and the control group (P<0.05); The level of serum IGFBP-3 in the two groups was higher than that before treatment, and the level of β- EP was lower than that before treatment (P<0.05), and there was significant difference between the observation group and the control group (P<0.05). There was no significant difference in the incidence of complications between the two groups (P>0.05).【Conclusion】 Caffeine citrate combined with noninvasive respiratory support model in the treatment of neonatal severe aspiration pneumonia can improve the indexes of pulmonary function and respiratory mechanics, and regulate serum IGFBP-3 and β- EP level, but transnasal synchronous intermittent positive pressure ventilation is better than transnasal continuous positive airway pressure ventilation.
Key wordsPneumonia, Aspiration/TH      Caffeine/TU      Respiration, Artificial      Infant, Newborn      Treatment Outcome     
Received: 06 December 2021     
PACS:  R725.631.9  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
Cite this article:   
URL:  
http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2022.04.013     OR     http://journal07.magtech.org.cn/yxlcyj/EN/Y2022/V39/I4/524
Copyright © Editorial Board of JOURNAL OF CLINICAL RESEARCH
Supported by:Beijing Magtech